четверг, 6 декабря 2012 г.

Bone Metastasis In Prostate Cancer Responds To Cabozantinib

A new drug demonstrated dramatic and rapid effects on prostate cancer that had spread to the bone, according to a study reported by University of Michigan Comprehensive Cancer Center researchers. About two-thirds of patients treated with cabozantinib had improvements on their bone scans, with 12 percent seeing complete resolution of uptake on bone scan...



Cancer-Medicine in USA

1 комментарий: